Analysis: Trump PEPFAR strategy, budget proposals add up to surrender in HIV battle

By on .

White House proposals to slash more than a billion dollars from U.S. supported HIV responses and limit efforts to control the epidemic to a handful of countries represents an unprecedented retreat from American leadership of the global fight against the disease and would reverse gains that were achieved, at a cost of more than $80 […]

Medical circumcision efforts gained ground against new HIV infections, but not enough

By on .

Focused efforts to protect men and boys from HIV led to more than 14.5 million medical circumcision procedures globally between 2008 and 2016, enough to avert an estimated half million infections by 2030, according to a report released today. That progress, however, falls at least 30 percent short of the nearly 21 million procedures originally […]

For people with HIV, viral suppression is critical to protection from yellow fever vaccine

By on .

A study on the effectiveness of the yellow fever vaccine among people living with HIV yields yet another reason that universal access to effective consistent antiretroviral medicine for people with the virus is important to global public health. The study, published in the recent Clinical Infectious Diseases found that the yellow fever vaccine offers long-term […]

IDWeek presenter highlights global implications of HIV treatment resistance in Philippines

By on .

Oct. 7, 2017 SAN DIEGO –  Dr. Edsel Salvaña has two posters in the exhibit hall here, each one carrying terrible news from the Philippines, that, if you pause to look at the one he stands in front of, he will cheerfully and concisely explain, has frightening implications well beyond his country. In fact, with […]

What we’re reading: Treatment is prevention, TB is a priority, welcome words and more

By on .

“This means that people who take ART daily as prescribed . . . and achieve and maintain an undetectable viral load have effectively no risk of sexually transmitting the virus to an HIV-negative partner . . .” With these words the U.S. Centers for Disease Control and Prevention effectively put on the record a truth […]

PrEP presents questions for HIV prevention researchers, survey seeks answers

By on .

The trial to determine the effectiveness of a vaccine against HIV that was known as HVTN 505 was underway in 2010 when results from another, wholly unrelated trial presented a challenge. Those results, from the iPrEx trial, showed that an antiretroviral drug taken as pre-exposure prophylaxis — or PrEP — was effective in protecting uninfected […]

Who needs infectious disease docs? Everyone . . .

By on .

Journal supplement delves into the rewards and challenges of chasing bugs no one wants to catch . . . Of all the specialties a young physician can enter, one that offers a career of saving lives and protecting communities, supporting social justice and alleviating suffering, while following questions and finding answers across health systems, neighborhoods […]

State Department, PEPFAR release good news and a “strategy” short on details, definition

By on .

Names 13 countries for “particular focus” with aim for epidemic control by 2020 . . . Botswana, Côte d’Ivoire, Haiti, Kenya, Lesotho, Malawi, Namibia, Rwanda, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe to be focus of efforts . . . Providing some clarification to proposals to shift the focus of the President’s Emergency Plan for AIDS Relief […]

Appropriators approve sustained global health, boost to TB, increased research funding, reject expanded global gag rule

By on .

“Now is not the time to back off,” Sen. Lindsay Graham (R-SC) Senate appropriators today approved spending for the coming fiscal year that would continue current funding levels for global health programs, add $2 billion to funding for the National Institutes of Health, including by maintaining the Fogarty International Center and its worldwide research and […]

Study finds small savings, high costs in both dollars and lives from global HIV funding cuts

By on .

“We leave it to readers to draw their own conclusions about whether imposing such tradeoffs on vulnerable populations accurately reflects how donor countries value life in recipient nations . . .” Walensky et al, Annals of Internal Medicine, August 28, 2017 Cutbacks to HIV services driven by diminishing donor dollars would result in reductions of […]